5.0 Abstract: Flow Cytometry Shared Service The mission of the Flow Cytometry Shared Service (FCSS) is to offer state-of-the-art instrumentation and technical expertise to UMGCC members to assist in the conduct of cancer biology research. The facility provides full-scale, state-of-the-art flow cytometry services including sample acquisition, data analysis, fluorescent cell sorting, experimental planning, and pre- and postexperimental consultation in support of NCI- sponsored research. The FCSS also assists investigators in the flow cytometry components of pilot grants supported by the NCI P30 funding and provides training on analytical instrumentation to users. The user training is designed to permit investigators to independently acquire samples and perform data analysis. The FCSS is committed to the dissemination of novel flow cytometry?based technologies through continuous education of UMGCC investigators. The FCSS has proved to be a key supporter of UMGCC and has supported over 50 UMGCC labs (out of more than 70 labs), leading to more than 90 peer-reviewed publications in the past 5 years. The FCSS has facilitated a wide range of basic science studies and has also had an important impact on clinical research efforts. In 2014, the FCSS supported 66 Cancer Center members spanning all 5 research programs (26 percent of all UMGCC members), with 42 of them (64 percent of UMGCC users) having peer-reviewed funding. The FCSS supports many cancer-related publications annually, with several in high-impact journals including Nature Communications, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences of the United States of America, and Blood.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA134274-09
Application #
9145399
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
9
Fiscal Year
2016
Total Cost
$125,544
Indirect Cost
$42,210
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Wang, Junxiang; Zhao, Liang; Ye, Yanfang et al. (2018) Adverse event detection by integrating twitter data and VAERS. J Biomed Semantics 9:19
Furusawa, Aki; Reiser, John; Sadashivaiah, Kavitha et al. (2018) Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy. J Immunother 41:53-63
Nathenson, Michael J; Conley, Anthony P; Sausville, Edward (2018) Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. Oncologist 23:71-83
Wang, Lei; Felts, Sara J; Van Keulen, Virginia P et al. (2018) Exploring the effect of library preparation on RNA sequencing experiments. Genomics :
Nathenson, Michael J; Barysauskas, Constance M; Nathenson, Robert A et al. (2018) Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma. World J Surg Oncol 16:203
Sallmyr, Annahita; Tomkinson, Alan E (2018) Repair of DNA double-strand breaks by mammalian alternative end-joining pathways. J Biol Chem 293:10536-10546
Kerr, Candace; Adhikary, Gautam; Grun, Daniel et al. (2018) Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Mol Carcinog 57:3-11
Connolly, Sean; Quasi-Woode, Devona; Waldron, Laura et al. (2018) Calcineurin Regulatory Subunit Calcium-Binding Domains Differentially Contribute to Calcineurin Signaling in Saccharomyces cerevisiae. Genetics 209:801-813
Pauza, C David; Liou, Mei-Ling; Lahusen, Tyler et al. (2018) Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Front Immunol 9:1305
Wang, Lei; Felts, Sara J; Van Keulen, Virginia P et al. (2018) Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients. Cancer Res 78:4411-4423

Showing the most recent 10 out of 257 publications